PHC Holdings Corporation (TYO:6523)

Market Cap	137.39B +14.1%
Revenue (ttm)	364.40B +0.8%
Net Income	492.00M -95.3%
EPS	3.87 -95.3%
Shares Out	126.51M
PE Ratio	280.62
Forward PE	8.86
Dividend	42.00 (3.87%)
Ex-Dividend Date	Mar 30, 2026

Volume	244,900
Open	1,079.00
Previous Close	1,084.00
Day's Range	1,064.00 - 1,094.00
52-Week Range	856.00 - 1,189.00
Beta	0.62
Analysts	Hold
Price Target	1,328.57 (+22.34%)
Earnings Date	May 13, 2026

About PHC Holdings

PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management; Healthcare Solutions; and Diagnostic and Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables; cell growth and preservation, such as CFC-free ultra-low temperature freezers, CO2 incubators, and live cell metabolic analyzer an...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1948
• Employees: 9,041
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 6523

Financial Performance

In fiscal year 2026, PHC Holdings's revenue was 364.40 billion, an increase of 0.78% compared to the previous year's 361.59 billion. Earnings were 492.00 million, a decrease of -95.31%.